GO:0004801 transaldolase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004801 transaldolase activity catalyzes the reversible transfer of a dihydroxyacetone moiety from sedoheptulose 7-phosphate to D-glyceraldehyde 3-phosphate, yielding D-erythrose 4-phosphate and D-fructose 6-phosphate.
• Transaldolase is a key enzyme of the non-oxidative branch of the pentose phosphate pathway, linking glycolytic and pentose phosphate intermediates.
• The reaction proceeds via a Schiff base intermediate formed between a catalytic lysine and the substrate, enabling stereospecific transfer without free dihydroxyacetone.
• Transaldolase 1 (TALDO1) is implicated in Parkinson's disease pathogenesis through metabolic reprogramming and autophagy-lysosomal dysfunction.
• TALDO1 deacetylation by HDAC6 promotes glycolysis and nasopharyngeal carcinoma progression via a moonlighting function.
• Transaldolase genes from fungi and archaea have been characterized, including Tal67 from Clonostachys rosea and the enzyme from Methanocaldococcus jannaschii.
Description
Transaldolase activity (GO:0004801) is a molecular function defined as the catalysis of the reaction: sedoheptulose 7-phosphate + D-glyceraldehyde 3-phosphate = D-erythrose 4-phosphate + D-fructose 6-phosphate. This reversible transfer reaction is a central step in the non-oxidative phase of the pentose phosphate pathway, interconverting sugar phosphates to meet cellular demands for ribose 5-phosphate, erythrose 4-phosphate, and glycolytic intermediates. The enzyme is widely distributed across archaea, bacteria, fungi, plants, and animals, and its catalytic mechanism has been studied in detail. Researchers study transaldolase activity because it connects carbohydrate metabolism to nucleotide biosynthesis, amino acid synthesis, and redox balance. Dysregulation of transaldolase has been linked to human diseases including Parkinson's disease and cancer, where metabolic reprogramming supports disease progression. Inborn errors affecting the pentose phosphate pathway, such as ribose-5-phosphate isomerase deficiency, highlight the importance of this metabolic network. This article provides a research-grade overview of GO:0004801, covering its definition, mechanism, key genes, disease associations, and experimental methods for studying transaldolase function in health and disease.
transaldolase activity At A Glance
| GO ID | GO:0004801 |
|---|---|
| GO term | transaldolase activity |
| Ontology | molecular_function |
| Synonym | dihydroxyacetone transferase activity; dihydroxyacetonetransferase activity; glycerone transferase activity; sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity |
| Definition | Catalysis of the reaction: sedoheptulose 7-phosphate + D-glyceraldehyde 3-phosphate = D-erythrose 4-phosphate + D-fructose 6-phosphate. |
| Major function | Reversible transfer of a dihydroxyacetone moiety between sugar phosphates in the non-oxidative pentose phosphate pathway. |
| Pathway context | Non-oxidative branch of the pentose phosphate pathway, linking glycolytic and pentose phosphate intermediates. |
| Catalytic mechanism | Schiff base intermediate with a catalytic lysine residue; stereospecific transfer without free dihydroxyacetone. |
| Representative enzymes | Transaldolase 1 (TALDO1) in humans; Tal67 in Clonostachys rosea; transaldolase in Methanocaldococcus jannaschii. |
What Is GO:0004801?
Transaldolase activity (GO:0004801) is the catalysis of a reversible aldol transfer reaction in which sedoheptulose 7-phosphate and D-glyceraldehyde 3-phosphate are converted to D-erythrose 4-phosphate and D-fructose 6-phosphate. The enzyme transfers a three-carbon dihydroxyacetone unit from the donor ketose (sedoheptulose 7-phosphate) to the acceptor aldose (D-glyceraldehyde 3-phosphate), forming a new carbon-carbon bond. This reaction is a core component of the non-oxidative pentose phosphate pathway and is essential for balancing metabolic flux between glycolysis and nucleotide precursor biosynthesis.
Why Is transaldolase activity Important in Cell Biology?
Transaldolase activity is essential for metabolic homeostasis because it connects the pentose phosphate pathway to glycolysis and provides precursors for nucleotide and amino acid biosynthesis. Its dysregulation has been directly linked to human disease: TALDO1 impacts Parkinson's disease pathogenesis via metabolic reprogramming and autophagy-lysosomal pathways, and deacetylation of TALDO1 by HDAC6 promotes glycolysis and nasopharyngeal carcinoma progression through a moonlighting function. Additionally, transaldolase genes from fungi and archaea have been characterized, expanding our understanding of this enzyme's diversity and biotechnological potential.
• Central to the non-oxidative pentose phosphate pathway, balancing carbon flux between glycolysis and nucleotide biosynthesis.
• Provides D-erythrose 4-phosphate for aromatic amino acid biosynthesis and D-fructose 6-phosphate for glycolysis.
• Implicated in Parkinson's disease through metabolic reprogramming and autophagy-lysosomal dysfunction.
• Promotes nasopharyngeal carcinoma progression via a moonlighting function regulated by HDAC6-mediated deacetylation.
• Fungal transaldolase Tal67 enhances biocontrol activity against Sclerotinia sclerotiorum.
• Archaeal transaldolase from Methanocaldococcus jannaschii provides insights into enzyme evolution and thermostability.
• Defects in the pentose phosphate pathway, including ribose-5-phosphate isomerase deficiency, cause neurological disease.
• Transaldolase is a potential therapeutic target in cancers with altered metabolic reprogramming.
• Enzyme's catalytic mechanism via Schiff base intermediate informs enzyme engineering and inhibitor design.
• Transaldolase activity can be measured to assess metabolic flux in cell models and disease research.
Molecular Mechanism of transaldolase activity
Substrate binding and Schiff base formation
In simple terms: The enzyme grabs the first sugar and holds it tightly by forming a temporary chemical bond.
Transaldolase catalyzes the reversible transfer of a dihydroxyacetone moiety from sedoheptulose 7-phosphate to D-glyceraldehyde 3-phosphate. The reaction begins with the formation of a Schiff base intermediate between the epsilon-amino group of a catalytic lysine residue and the carbonyl group of sedoheptulose 7-phosphate. This covalent intermediate stabilizes the carbanion and allows stereospecific transfer of the three-carbon unit without releasing free dihydroxyacetone.
Catalytic transfer and product release
In simple terms: The enzyme moves a three-carbon piece from one sugar to another, creating two new sugars.
Following Schiff base formation, the dihydroxyacetone moiety is transferred to the acceptor substrate D-glyceraldehyde 3-phosphate, yielding D-erythrose 4-phosphate and D-fructose 6-phosphate. The reaction is reversible and operates near equilibrium in vivo, allowing the enzyme to respond to metabolic demands. The catalytic mechanism has been studied in detail, including in archaeal transaldolases such as that from Methanocaldococcus jannaschii.
Role in the non-oxidative pentose phosphate pathway
In simple terms: This enzyme is a key connector in a metabolic pathway that makes building blocks for DNA and proteins.
Transaldolase activity is a core component of the non-oxidative branch of the pentose phosphate pathway, interconverting sugar phosphates to maintain pools of ribose 5-phosphate, erythrose 4-phosphate, and glycolytic intermediates. This pathway is essential for nucleotide biosynthesis and for providing reducing power in the form of NADPH. The enzyme's activity is particularly important in tissues with high biosynthetic demands, such as liver and rapidly proliferating cells.
Moonlighting functions and regulation
In simple terms: The enzyme can have additional jobs beyond its classic metabolic role, especially in cancer cells.
Beyond its canonical catalytic function, TALDO1 has been shown to possess a moonlighting function in nasopharyngeal carcinoma, where deacetylation by HDAC6 promotes glycolysis and tumor progression. In Parkinson's disease, TALDO1 impacts pathogenesis via metabolic reprogramming and the autophagy-lysosomal pathway. These findings indicate that transaldolase activity is integrated into broader cellular regulatory networks beyond simple metabolic flux.
Key Genes Involved in GO:0004801 transaldolase activity
The following genes and proteins are directly associated with transaldolase activity (GO:0004801) or its metabolic context, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TALDO1 | Human transaldolase 1; catalyzes the reversible transfer of dihydroxyacetone in the pentose phosphate pathway | Implicated in Parkinson's disease and nasopharyngeal carcinoma; target for metabolic studies |
| Tal67 | Transaldolase from Clonostachys rosea 67-1; enhances biocontrol activity against Sclerotinia sclerotiorum | Biocontrol and fungal genetics research |
| M. jannaschii transaldolase | Archaeal transaldolase; model for enzyme structure and thermostability | Enzyme evolution and biocatalysis studies |
| RPI A | Ribose-5-phosphate isomerase A; adjacent pentose phosphate pathway enzyme | Overexpression promotes liver cancer via ERK and β-catenin pathways |
| HDAC6 | Deacetylates TALDO1, promoting glycolysis and nasopharyngeal carcinoma progression | Epigenetic regulation of metabolic enzymes in cancer |
| GAPDH | Glycolytic enzyme; provides D-glyceraldehyde 3-phosphate for transaldolase reaction | Metabolic flux studies |
| TKT | Transketolase; adjacent non-oxidative pentose phosphate pathway enzyme | Metabolic pathway research |
| RPE | Ribulose-5-phosphate 3-epimerase; pentose phosphate pathway enzyme | Metabolic pathway research |
| RPI | Ribose-5-phosphate isomerase; pentose phosphate pathway enzyme | Deficiency causes leukoencephalopathy |
| PFK | Phosphofructokinase; glycolytic enzyme linked to fructose 6-phosphate pool | Glycolysis regulation |
| FBP | Fructose-1,6-bisphosphatase; gluconeogenic enzyme | Metabolic flux studies |
| PRPS | Phosphoribosyl pyrophosphate synthetase; uses ribose 5-phosphate | Nucleotide biosynthesis research |
| G6PD | Glucose-6-phosphate dehydrogenase; oxidative pentose phosphate pathway | Redox balance and disease research |
| 6PGD | 6-phosphogluconate dehydrogenase; oxidative pentose phosphate pathway | Metabolic studies |
| L-threonine transaldolase | Enzyme with transaldolase-like activity; persistent catalytic intermediate | Biocatalysis and enzyme mechanism studies |
How Is transaldolase activity Regulated?
Transaldolase activity is regulated at multiple levels. The enzyme's catalytic activity is influenced by substrate availability and the redox state of the cell, as it operates within the pentose phosphate pathway. In cancer, TALDO1 is regulated by acetylation: HDAC6-mediated deacetylation of TALDO1 promotes glycolysis and nasopharyngeal carcinoma progression, indicating post-translational modification as a key regulatory mechanism. In Parkinson's disease, TALDO1 impacts pathogenesis via metabolic reprogramming and the autophagy-lysosomal pathway, suggesting that cellular stress responses can modulate its function. Additionally, the expression of transaldolase genes may be subject to transcriptional regulation in response to metabolic demands, although specific transcription factors are not fully defined in the cited literature.
transaldolase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TALDO1 | Parkinson's disease; metabolic reprogramming and autophagy-lysosomal pathway | TALDO1 knockout or overexpression in neuronal cell lines; patient-derived iPSCs |
| TALDO1 | Nasopharyngeal carcinoma; HDAC6-mediated deacetylation promotes glycolysis | TALDO1 point mutant (acetylation-deficient) knock-in in cancer cell lines |
| RPI A | Liver cancer; activation of ERK and β-catenin pathways | Transgenic zebrafish overexpressing RPI A |
| RPI | Ribose-5-phosphate isomerase deficiency; leukoencephalopathy | Patient-derived fibroblasts or iPSCs with RPI mutations |
| Tal67 | Fungal biocontrol against Sclerotinia sclerotiorum | Tal67 knockout or overexpression in Clonostachys rosea |
Transaldolase in Parkinson's disease
Transaldolase 1 (TALDO1) impacts Parkinson's disease pathogenesis via metabolic reprogramming and the autophagy-lysosomal pathway. This study suggests that altered transaldolase activity contributes to the metabolic and autophagic dysfunction observed in Parkinson's disease models, highlighting the enzyme as a potential therapeutic target.
Transaldolase in nasopharyngeal carcinoma
Deacetylation of TALDO1 by HDAC6 promotes glycolysis and nasopharyngeal carcinoma progression through a moonlighting function. This finding links transaldolase activity to cancer metabolism and suggests that targeting TALDO1 or its regulatory acetylation may have therapeutic potential in nasopharyngeal carcinoma.
Pentose phosphate pathway defects and leukoencephalopathy
Ribose-5-phosphate isomerase deficiency, a defect in the pentose phosphate pathway, is associated with a slowly progressive leukoencephalopathy. Although this defect is not in transaldolase itself, it highlights the clinical importance of the non-oxidative pentose phosphate pathway, of which transaldolase activity is a core component.
Transaldolase in liver cancer
Ribose-5-phosphate isomerase A overexpression promotes liver cancer development in transgenic zebrafish via activation of ERK and β-catenin pathways. This study underscores the role of pentose phosphate pathway enzymes, including those adjacent to transaldolase, in hepatocarcinogenesis.
From transaldolase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of TALDO1 affect Parkinson's disease-related phenotypes? | TALDO1 knockout in neuronal cell lines or iPSC-derived neurons |
| Does acetylation of TALDO1 regulate its moonlighting function in cancer? | Point mutation at acetylation sites (e.g., K to R) knock-in in nasopharyngeal carcinoma cells |
| Can TALDO1 overexpression drive metabolic reprogramming? | TALDO1 overexpression in cancer cell lines followed by metabolic assays |
| What is the role of transaldolase in fungal biocontrol? | Tal67 knockout or overexpression in Clonostachys rosea |
| How does transaldolase contribute to pentose phosphate pathway flux? | Knockout of TALDO1 in cell lines followed by metabolomics and flux analysis |
| Can transaldolase activity be targeted for cancer therapy? | TALDO1 knockout or point mutation in cancer cell lines and xenograft models |
How to Study the transaldolase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Enzymatic activity assay | Transaldolase catalytic rate and kinetics | Validation of knockout/overexpression models |
| Metabolomics | Levels of sugar phosphates and pathway intermediates | Metabolic reprogramming studies |
| 13C flux analysis | Carbon flux through pentose phosphate pathway | Quantifying transaldolase contribution to metabolism |
| CRISPR knockout screen | Genes affecting transaldolase activity or pathway | Discovery of genetic interactions |
| Immunoprecipitation-mass spectrometry | Acetylation and post-translational modifications of TALDO1 | Studying moonlighting functions |
| Western blot | Protein expression levels of TALDO1 and pathway enzymes | Model validation |
| RNA-seq | Transcriptional changes upon TALDO1 manipulation | Pathway analysis |
| Autophagy flux assay | Autophagy-lysosomal pathway activity | Parkinson's disease research |
Enzymatic activity assays
Transaldolase activity can be measured spectrophotometrically by coupling the reaction to NADH oxidation or by using mass spectrometry to detect substrate and product levels. These assays are essential for validating knockout or overexpression models and for determining kinetic parameters.
Metabolomics and flux analysis
Metabolomic profiling and 13C flux analysis allow researchers to trace carbon flow through the pentose phosphate pathway and quantify the contribution of transaldolase activity to metabolic networks. These methods are particularly useful in cancer and neurodegeneration studies where metabolic reprogramming occurs.
CRISPR-based genetic screens
CRISPR knockout screens can identify genes that modulate transaldolase activity or compensate for its loss, providing insights into genetic interactions and pathway redundancy. Such screens are valuable for discovering therapeutic targets in metabolic diseases.
Protein acetylation and post-translational modification analysis
Immunoprecipitation followed by mass spectrometry can detect acetylation of TALDO1 and other post-translational modifications that regulate its activity. These methods are critical for understanding the moonlighting functions of transaldolase in cancer.
How CRISPR Can Be Used to Study GO:0004801 transaldolase activity
Knockout
CRISPR knockout of TALDO1 or other transaldolase genes allows researchers to study the loss-of-function consequences on pentose phosphate pathway flux, cell proliferation, and disease phenotypes. Knockout cell lines are essential for validating the role of transaldolase in metabolic reprogramming and autophagy-lysosomal pathways.
Point Mutation
Point mutations can be introduced into TALDO1 to study catalytic residues, acetylation sites, or disease-associated variants. For example, mutation of the catalytic lysine involved in Schiff base formation can abolish enzymatic activity, while acetylation-site mutants can reveal regulatory mechanisms.
Knock-in
Knock-in of tagged TALDO1 (e.g., FLAG or GFP) enables protein localization, interaction, and acetylation studies. Knock-in of disease-relevant mutations can model human conditions such as Parkinson's disease or cancer-associated metabolic alterations.
Overexpression
Overexpression of TALDO1 or transaldolase genes from other species (e.g., Tal67) can drive metabolic reprogramming and enhance specific phenotypes, such as biocontrol activity or tumor progression. Overexpression models are useful for gain-of-function studies and for testing therapeutic interventions.
How EDITGENE Supports transaldolase activity Research
Researchers studying transaldolase activity-related genes often need to determine whether a candidate gene is causally involved in metabolic reprogramming, disease progression, or cellular stress responses. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models, enabling rigorous functional validation of transaldolase and its regulatory network.
Contact EDITGENE today to design your custom CRISPR model for transaldolase activity research.
Frequently Asked Questions About transaldolase activity
What is transaldolase activity?
Transaldolase activity (GO:0004801) is the catalysis of the reversible reaction: sedoheptulose 7-phosphate + D-glyceraldehyde 3-phosphate = D-erythrose 4-phosphate + D-fructose 6-phosphate.
What genes are involved in transaldolase activity?
The primary human gene is TALDO1, encoding transaldolase 1. Other genes include Tal67 from Clonostachys rosea and transaldolase from Methanocaldococcus jannaschii.
What is the role of transaldolase in the pentose phosphate pathway?
Transaldolase is a core enzyme of the non-oxidative branch, interconverting sugar phosphates to maintain ribose 5-phosphate and glycolytic intermediates.
How is transaldolase activity regulated?
It is regulated by substrate availability, cellular redox state, and post-translational modifications such as acetylation by HDAC6.
What diseases are associated with transaldolase dysfunction?
Transaldolase 1 is implicated in Parkinson's disease and nasopharyngeal carcinoma. Pentose phosphate pathway defects cause leukoencephalopathy.
How can I measure transaldolase activity in the lab?
Enzymatic assays, metabolomics, and 13C flux analysis are commonly used to measure transaldolase activity.
What is the catalytic mechanism of transaldolase?
It proceeds via a Schiff base intermediate with a catalytic lysine residue, enabling stereospecific transfer of a dihydroxyacetone moiety.
Can CRISPR be used to study transaldolase function?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are powerful tools for studying transaldolase function in disease and metabolism.
What is the connection between transaldolase and cancer?
TALDO1 deacetylation by HDAC6 promotes glycolysis and nasopharyngeal carcinoma progression via a moonlighting function.
Where can I get CRISPR cell models for transaldolase research?
EDITGENE provides custom CRISPR services including knockout, point mutation, knock-in, overexpression, and library screening for transaldolase-related genes.
Conclusion
Transaldolase activity (GO:0004801) is a fundamental molecular function in the non-oxidative pentose phosphate pathway, with critical roles in metabolic homeostasis and human disease. Its catalytic mechanism via a Schiff base intermediate is well characterized, and emerging evidence links TALDO1 to Parkinson's disease and cancer through metabolic reprogramming and moonlighting functions. Continued research using CRISPR-based models and advanced metabolomic methods will further elucidate the therapeutic potential of targeting transaldolase activity.
References
- 1. Kumar P et al.. 2021. l-Threonine Transaldolase Activity Is Enabled by a Persistent Catalytic Intermediate.. ACS Chem Biol 16(1):86-95 PMID: 33337128
- 2. Chou YT et al.. 2019. Ribose-5-phosphate isomerase A overexpression promotes liver cancer development in transgenic zebrafish via activation of ERK and β-catenin pathways.. Carcinogenesis 40(3):461-473 PMID: 30418535
- 3. Liu JY et al.. 2016. Transaldolase gene Tal67 enhances the biocontrol activity of Clonostachys rosea 67-1 against Sclerotinia sclerotiorum.. Biochem Biophys Res Commun 474(3):503-508 PMID: 27130824
- 4. Tan Z et al.. 2025. Transaldolase 1 impacts Parkinson's disease pathogenesis via metabolic reprogramming and autophagy-lysosomal pathway.. Acta Neuropathol Commun 13(1):223 PMID: 41189023
- 5. Huck JH et al.. 2004. Ribose-5-phosphate isomerase deficiency: new inborn error in the pentose phosphate pathway associated with a slowly progressive leukoencephalopathy.. Am J Hum Genet 74(4):745-51 PMID: 14988808
- 6. Soderberg T et al.. 2004. Transaldolase of Methanocaldococcus jannaschii.. Archaea 1(4):255-62 PMID: 15810435
- 7. Samland AK et al.. 2009. Transaldolase: from biochemistry to human disease.. Int J Biochem Cell Biol 41(7):1482-94 PMID: 19401148
- 8. Peng X et al.. 2025. Deacetylation of TALDO1 by HDAC6 promotes glycolysis and nasopharyngeal carcinoma progression through a moonlighting function.. Cell Death Dis 16(1):743 PMID: 41120289
